Samuel K. Ackerman
Directeur Général chez Cyclis Pharmaceuticals, Inc.
Profil
Samuel K.
Ackerman is the founder of Pentose Pharmaceuticals, Inc. He currently holds the position of President & Chief Executive Officer at Cyclis Pharmaceuticals, Inc. and Chairman at Vitex Systems, Inc. Previously, he served as Chairman & Chief Executive Officer at V.I.
Technologies, Inc. from 1999 to 2005, Chairman, President & Chief Executive Officer at Panacos Pharmaceuticals, Inc. from 2005 to 2006, and as a Principal at OraVax, Inc. in 1995.
He also worked as a Partner at Ampersand Management LLC.
Postes actifs de Samuel K. Ackerman
| Sociétés | Poste | Début |
|---|---|---|
Cyclis Pharmaceuticals, Inc.
 Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyclis Pharmaceuticals, Inc. researches and develops small molecule drugs for the treatment of cancer. It is engaged in the discovery and development of novel drugs which are based on the restoration and activation of cellular checkpoints. The company is headquartered in Norwood, MA. | Directeur Général | - |
| Vitex Systems, Inc. | Président | - |
Anciens postes connus de Samuel K. Ackerman
| Sociétés | Poste | Fin |
|---|---|---|
| PANACOS PHARMACEUTICALS, INC. | Directeur Général | 15/06/2006 |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Président | 01/08/2005 |
OraVax, Inc.
 OraVax, Inc. BiotechnologyHealth Technology Part of Sanofi, OraVax, Inc. is a company that has a slick name that taps into the words 'oral' and 'vaccine' in a subtle way. The company is based in Cambridge, MA. The company is a possible oral health brand, medical licensing service, app, or chemicals company. OraVax was acquired by Acambis Plc, part of Sanofi from September 22, 2008 on May 11, 1999 for $17.79 million. | Corporate Officer/Principal | 31/12/1995 |
Pentose Pharmaceuticals, Inc.
 Pentose Pharmaceuticals, Inc. BiotechnologyHealth Technology Pentose Pharmaceuticals, Inc. develops and commercializes novel antiviral products for medical use based on innovative applications of nucleic acid chemistry. Pentose is a privately held biopharmaceutical company founded in 1995 and is based in Cambridge, Massachusetts. | Fondateur | - |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Private Equity Investor | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Finance |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
OraVax, Inc.
OraVax, Inc. BiotechnologyHealth Technology Part of Sanofi, OraVax, Inc. is a company that has a slick name that taps into the words 'oral' and 'vaccine' in a subtle way. The company is based in Cambridge, MA. The company is a possible oral health brand, medical licensing service, app, or chemicals company. OraVax was acquired by Acambis Plc, part of Sanofi from September 22, 2008 on May 11, 1999 for $17.79 million. | Health Technology |
Cyclis Pharmaceuticals, Inc.
Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cyclis Pharmaceuticals, Inc. researches and develops small molecule drugs for the treatment of cancer. It is engaged in the discovery and development of novel drugs which are based on the restoration and activation of cellular checkpoints. The company is headquartered in Norwood, MA. | Health Technology |
| Vitex Systems, Inc. | |
Pentose Pharmaceuticals, Inc.
Pentose Pharmaceuticals, Inc. BiotechnologyHealth Technology Pentose Pharmaceuticals, Inc. develops and commercializes novel antiviral products for medical use based on innovative applications of nucleic acid chemistry. Pentose is a privately held biopharmaceutical company founded in 1995 and is based in Cambridge, Massachusetts. | Health Technology |
